ORIC Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing innovative therapies to combat cancer resistance. Their pipeline features unique candidates like rinzimetostat and enozertinib, targeting specific genetic mutations in cancer, with the mission of improving patient outcomes.
No jobs found. Subscribe below to get notified when we find something for you.
Searching